PLASMA THERAPY

Oct. 27, 2020

Recently published findings on convalescent plasma therapy on Covid-19 patients have triggered a debate over its efficacy.

About:

  • After the country’s largest such trial, known by the acronym PLACID, found that convalescent plasma was ineffective in arresting Covid-19, the Indian Council of Medical Research (ICMR) has been considering dropping this option from the national guidelines.

  • Plasma is the liquid part of the blood. Convalescent plasma, extracted from the blood of patients recovering from an infection, is a source of antibodies against the infection.

  • The Plasma therapy involves using their plasma to help others recover. For Covid-19, this has been one of the treatment options. The donor would have to be a documented case of Covid-19 and healthy for 28 days since the last symptoms.